NRTI resistance associated with the RT mutation K70E in HIV-1

被引：0
|
作者：
Van Houtte, M.
Staes, M.
Geretti, A. M.
Pattery, T.
Bacheler, L.
机构：
[1] Vicro BVBA, Mechelen, Belgium
[2] UCL Royal Free Hosp, London NW3 2QG, England
[3] UCL Royal Free & Univ Coll Med Sch, London, England
[4] Vicro Lab Inc, Durham, NC USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir
    Kagan, R
    Ross, L
    Winters, M
    Merigan, T
    Heseltine, P
    Lewinski, M
    ANTIVIRAL THERAPY, 2005, 10 : S103 - S103
  • [2] Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir
    Kagan, R
    Ross, L
    Winters, M
    Merigan, T
    Heseltine, P
    Lewinski, M
    ANTIVIRAL THERAPY, 2005, 10 (04) : S103 - S103
  • [3] National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation
    Delaugerre, C.
    Flandre, P.
    Marcelin, A. G.
    Descamps, D.
    Tamalet, C.
    Cottalorda, J.
    Schneider, V.
    Yerly, S.
    LeGoff, J.
    Joubert, L. Morand
    Chaix, M. L.
    Costagliola, D.
    Calvez, V.
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (05) : 762 - 765
  • [4] Relative fitness and tenofovir resistance levels of K70E and K65R HIV-1 RT mutants favours selection of K65R over K70E viruses in the presence of tenofovir
    Svarovskaia, E. S.
    Goodman, D.
    Ly, J.
    Eastoak-Siletz, A.
    White, K.
    LaFlamme, G.
    Margot, N. A.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2007, 12 : S110 - S110
  • [5] Relative fitness and tenofovir resistance levels of K70E and K65R HIV-1 RT mutants favours selection of K65R over K70E viruses in the presence of tenofovir
    Svaropskaia, E. S.
    Goodman, D.
    Ly, J.
    Eastoak-Siletz, A.
    White, K.
    LaFlamme, G.
    Margot, N. A.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S110 - S110
  • [6] Selection of the HIV-1 reverse transcriptase mutation K70E in antiretroviral-naive subjects treated with tenfovir/abacavir/lamivudine therapy
    Ross, L
    Gerondelis, P
    Liao, Q
    Wine, B
    Lim, M
    Shaefer, M
    Rodríguez, A
    Limoli, K
    Huang, W
    Parkin, NT
    Gallant, J
    Lanier, R
    ANTIVIRAL THERAPY, 2005, 10 (04) : S102 - S102
  • [7] Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
    Kagan, R. M.
    Lee, T.-S.
    Ross, L.
    Lloyd, R. M., Jr.
    Lewinski, M. A.
    Potts, S. J.
    ANTIVIRAL RESEARCH, 2007, 75 (03) : 210 - 218
  • [8] Selection of the HIV-1 reverse transcriptase mutation K70E in antiretroviral-naive subjects treated with tenfovir/abacavir/lamivudine therapy
    Ross, L
    Gerondelis, P
    Liao, Q
    Wine, B
    Lim, M
    Shaefer, M
    Rodriguez, A
    Limoli, K
    Huang, W
    Parkin, NT
    Gallant, J
    Lanier, R
    ANTIVIRAL THERAPY, 2005, 10 : S102 - S102
  • [9] Residue K70 in HIV-1 reverse transcriptase: a crossroad between excision and discrimination mechanisms of NRTI resistance
    Zelina, S.
    Sheen, C-W
    Mellors, J.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S159 - S159
  • [10] HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation
    Boucher, S.
    Recordon-Pinson, P.
    Ragnaud, J. M.
    Dupon, M.
    Fleury, H.
    Masquelier, B.
    HIV MEDICINE, 2006, 7 (05) : 294 - 298
12345